Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin
Authors:
- Jingjing DingJDJingjing Ding
- Haiyan MinHMHaiyan Min
- Yanting WenYWYanting Wen
- Qian GaoQGQian Gao
- 1 November 2013
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 17 (3) , 752-758
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81030013, 81100386)
- Ministry of Education of the People's Republic of China (20110091120031)
- Ministry of Science and Technology of the People's Republic of China (2009CB918704)
- Fundamental Research Funds for the Central Universities (1107021461)
This publication has 34 references indexed in Scilit:
- Inflammation in Diabetic NephropathyMediators of Inflammation, 2012
- Heme Oxygenase-1 as a Target for TGF-β in Kidney DiseaseSeminars in Nephrology, 2012
- Role of T Cells in Type 2 Diabetic NephropathyExperimental Diabetes Research, 2011
- Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic NephropathyDiabetes, 2011
- Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 DiabetesDiabetes, 2011
- Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 DiabetesThe Journal of Immunology, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Human regulatory T cells and autoimmunityEuropean Journal of Immunology, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006